Literature DB >> 8206514

Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition.

H Rothe1, C Ongören, S Martin, P Rösen, H Kolb.   

Abstract

Upon stimulation with lipopolysaccharide (LPS), peritoneal macrophages from diabetes-prone Bio-Breeding (BB) rats secrete more tumour necrosis factor-alpha (TNF-alpha) than macrophages from diabetes-resistant BB or normal Wistar rats. Enhanced transcription was demonstrated by Northern blot analysis and at the single cell level by mRNA: RNA hybridization. Cytofluorometry analysis showed 2-4 times more plasma membrane and total cell-associated TNF-alpha in macrophages of diabetes-prone BB rats. The analysis of fluorescence intensity showed a single peak, and TNF-alpha mRNA was found in > 90% of macrophages. These findings exclude TNF hypersecretion as being due to an abnormal subfraction of cells. TNF-alpha gene hyperexpression in diabetes-prone BB rats was not due to mutations in the regulatory regions of the promoter, which could be shown by cloning and sequencing of the TNF-alpha promoter in the three rat strains. When searching for other regulatory defects we found the production of prostaglandin E2 (PGE2) in response to LPS to be up to 10 times lower in macrophages from diabetes-prone BB rats than from Wistar rats. Furthermore, BB rats macrophages required significantly higher concentrations of PGE2 for suppression of TNF-alpha secretion. We conclude that abnormal TNF-alpha production in macrophages from diabetes-prone BB rats is due to enhanced gene transcription and translation and that this is associated with defective PGE2 feedback inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206514      PMCID: PMC1422338     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.

Authors:  E Sariban; K Imamura; R Luebbers; D Kufe
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

3.  Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; Y M Snyder; W D Roeder
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.

Authors:  L Fransen; R Müller; A Marmenout; J Tavernier; J Van der Heyden; E Kawashima; A Chollet; R Tizard; H Van Heuverswyn; A Van Vliet
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

7.  Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides.

Authors:  H Renz; J H Gong; A Schmidt; M Nain; D Gemsa
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

9.  Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME).

Authors:  P Scuderi
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1.

Authors:  C Pukel; H Baquerizo; A Rabinovitch
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

View more
  1 in total

1.  Tumor necrosis factor α decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Nancy J Hong; Jeffrey L Garvin
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.